The Quiet Exit From Independent Practice
Oral surgery has long been one of the last bastions of truly independent specialty medicine. Unlike primary care or even general dentistry, oral surgeons built practices anchored in referral relationships, surgical reputation, and years of cultivated trust with local dentists and patients. That model sustained itself for decades. Now, dental service organizations – DSOs – are moving aggressively into the specialty, and a growing number of regional oral surgery groups are taking their offers seriously.
The transactions are rarely announced with fanfare. A multi-location oral surgery practice in a mid-sized metro area signs a letter of intent, undergoes due diligence, and closes a deal that folds its operations into a national or regional DSO network. The surgeons stay on, often under employment agreements, and patients typically notice nothing different at the front desk. What changes is everything behind the scenes: ownership, billing infrastructure, purchasing contracts, and long-term strategic direction.
Why DSOs Want Oral Surgery Now
Oral surgery generates significantly higher revenue per procedure than general dentistry. Wisdom tooth extractions, dental implants, bone grafting, and corrective jaw surgeries carry price points that make the specialty attractive to any organization trying to build a high-margin dental platform. DSOs that started by acquiring general dentistry practices are now looking upmarket, and oral surgery sits at the top of that chain. A single oral surgeon operating efficiently can produce more revenue in a morning than several general dentists working the same shift.
The consolidation logic tracks closely with what has already happened in regional ambulance services and other healthcare niches absorbed by private equity networks – the underlying business has predictable demand, limited competition from retail substitutes, and real pricing power. Oral surgery checks all those boxes. Implants alone represent a rapidly expanding market segment as an aging population increasingly opts for permanent tooth replacement over dentures. DSOs with scale can negotiate better lab rates, supply costs, and insurance reimbursements, which means a practice that was profitable as a standalone becomes more profitable inside a network.
What Selling Surgeons Are Actually Getting
The financial structure of these deals matters enormously to understanding why independent surgeons are willing to sell. Most transactions involve an upfront cash payment that represents a multiple of the practice’s annual earnings – typically structured as EBITDA, meaning earnings before interest, taxes, depreciation, and amortization. For a surgeon approaching retirement, or a small group that built strong revenue over two decades, those multiples can represent life-changing liquidity that simply was not available a generation ago.
Younger surgeons in these groups often receive a second layer of compensation through equity stakes in the acquiring DSO or its parent entity. The pitch is straightforward: take cash now, keep working, and participate in the upside when the DSO eventually sells to a larger platform or goes public. It is a compelling enough structure that surgeons who never planned to sell are at least scheduling conversations with DSO representatives to understand what their practice is worth on the current market.
There is also a genuine administrative relief factor driving interest. Running an independent specialty practice in 2025 involves managing prior authorizations, fighting insurance claim denials, hiring and retaining qualified staff in a tight labor market, and staying current with compliance requirements across multiple fronts. Many oral surgeons describe the administrative load as having expanded substantially over the past decade, eating into time they would rather spend on clinical work. DSOs absorb much of that burden through centralized back-office operations, which is a real benefit even for surgeons who are ambivalent about giving up ownership.
The tradeoffs are significant, though. Surgeons who sell typically give up final say over staffing decisions, supply choices, and in some cases, treatment planning protocols. DSOs focused on efficiency metrics may push for faster patient throughput than a surgeon considers ideal. Fee schedules for procedures get standardized across the network, which can mean lower per-procedure rates in markets where the independent practice had negotiated strong insurance contracts. The autonomy that drew most oral surgeons to private practice does not transfer with the sale.
How Regional Markets Are Shifting
In any given mid-sized metro area, there may be a handful of established oral surgery groups that have traded referrals, competed for hospital privileges, and built their reputations over decades. When one of those groups sells to a DSO, it changes the competitive landscape for everyone else. The DSO-backed practice gains access to a national marketing budget, a standardized patient experience platform, and cross-referral pipelines from other DSO-affiliated general dentistry practices in the same market. Independent practices suddenly find themselves competing against an entity with structural advantages they cannot easily replicate.
This dynamic accelerates further consolidation. Oral surgeons who might have been content to remain independent start calculating how long they can hold competitive ground as more of the local market gets absorbed. Some choose to sell before the window narrows further. Others double down on the referral relationships and clinical reputation that DSOs cannot easily replicate with a network playbook. The practices that are weathering the pressure best tend to be those with the deepest ties to specific referring dentists and the strongest name recognition for complex surgical cases that require genuine specialist expertise.
The Regulatory Gap Nobody Is Talking About
Corporate practice of medicine laws exist in many states to limit the degree to which non-physician entities can direct clinical decision-making. Dentistry has its own version of these restrictions – corporate practice of dentistry laws – that technically prohibit non-dentists from owning dental practices in a number of states. DSOs navigate this through management services agreements, where the corporate entity owns everything except the clinical practice itself, which remains nominally owned by a licensed dentist. This structure is legal, but it creates a layer of contractual complexity that can obscure who is actually making the decisions that shape patient care.
State dental boards vary widely in how aggressively they interpret and enforce these statutes, which means the regulatory environment a DSO-backed oral surgery practice operates in depends heavily on geography. A group selling in one state may find its surgeons have substantially more clinical autonomy post-sale than a comparable group selling in another state, not because of anything the DSO does differently, but because of how local rules interact with the management agreement structure. Patients and referring dentists generally have no visibility into these arrangements.
What nobody in the DSO industry wants to discuss openly is the question of what happens to these networks if the private equity capital backing them pulls back. DSO platforms are often leveraged heavily, built on the assumption that growth through acquisition justifies the debt load and produces an eventual exit at a higher multiple. If that exit does not materialize on the expected timeline, the pressure on individual practices within the network to cut costs and increase throughput intensifies. The surgeons who traded independence for a steady salary and a promised equity payout are not holding a liquid asset if the platform runs into trouble – they are holding an employment contract.
